Quick Question Archives
- What is the FDA-approved assay for anti-Xa DOACs? - 109 votes - open
- How do you measure factor IX therapy? - 51 votes - open
- How do you measure factor VIII therapy? - 55 votes - open
- How do you measure the oral anti-Xa anticoagulants rivaroxaban, apixaban, edoxaban, and betrixaban? - 98 votes - open
- How do you measure the oral direct thrombin inhibitor dabigatran? - 99 votes - open
- What controls are most valid for managing D-dimer assay precision? - 35 votes - open
- What method do you use to measure von Willebrand factor activity? - 60 votes - open
- How do you establish a coag factor reference interval? - 47 votes - open
- When is the correct time to label blood specimen tubes? - 140 votes - open
- When should you perform an antithrombin, protein C, and protein S profile? - 76 votes - open
- Our QQ this month is a quiz question with one correct answer. You perform platelet aggregometry. Aggregation results are normal in response to all agonists except ristocetin. You rule out VWD. What diagnosis could it be? - 77 votes - closed
- How do you assay for direct oral anti-Xa antithrombotics like rivaroxaban? - 78 votes - open
- How do you test for fibrinolysis? - 103 votes - open
- How do you store plasma specimens when coagulation testing is delayed to beyond 48 hours? - 109 votes - open
- In a PTT mixing study, the patient's initial PTT is 67 s, RI 25–35. The PTT is repeated after mixing 1:1 with NP, and the new result is 63 s, NP 30 s. What do you do next? - 102 votes - open
